James Pickett manages the grant funding programmes at Alzheimer’s Society, contributes the overall strategy direction of the research agenda and the development of new research partnerships and collaborations. Since 2006, Alzheimer’s Society and ARUK have supported a prospective UK programme of Brain banking. Previous James worked for Diabetes UK and as an editor at Nature Reviews Molecular Cell Biology. He completed his PhD in molecular pharmacology from the University of Cambridge.
Click here to go back to panel discussion.